thisdrug what a medicine's name tells you

WHO naming stem · suffix · 831 listed names

-mab

This page was written with AI.

monoclonal antibodies (previous naming scheme)

WHO's definition, quoted as written in the 2024 stem book

159 of 831 names appear in these lists: 142 in the US list (FDA Drugs@FDA) and 144 in the EU central list (EMA); 125 have national brands in at least one EU/EEA country.

Names only. This page is about -mab as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -mab. So the letters mab sit at the end of the name (…mab).

All 831 names WHO lists under -mab

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 159 of 831 names appear in these lists: 142 in the US list (FDA Drugs@FDA) and 144 in the EU central list (EMA); 125 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. abrezekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. acapatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. acasunlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. acrixolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. adabrelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. adalimumab
    EU (central) brands: Amgevita, Amsparity, Hefiya, Hukyndra, Hulio, Humira, Hyrimoz, Idacio, Imraldi, Libmyris, Yuflyma, Cyltezo (withdrawn)
    4 moreHalimatoz (withdrawn), Kromeya (withdrawn), Solymbic (withdrawn), Trudexa (withdrawn)
  7. adalimumab beta
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. adalimumab fosimdesonide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. alemtuzumab
    US brands: CAMPATH, LEMTRADA
    EU (central) brands: Lemtrada, MabCampath (withdrawn)
  10. alemtuzumab beta
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. alnuctamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. alomfilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. alsevalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. altumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. amlitelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. amubarvimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. anatumomab mafenatox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. anbenitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. anetumab corixetanglo
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. anetumab ravtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. anifrolumab
    US brands: SAPHNELO
    EU (central) brands: Saphnelo
  22. anivovetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. anselamimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. ansuvimab
    US brands: EBANGA
    EU (central) brands: none found
  25. anumigilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. apamistamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  27. aprutumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. aprutumab ixadotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. arcitumomab
    US brands: none found
    EU (central) brands: CEA-Scan (withdrawn)
  30. ascrinvacumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. aselizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. astegolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  33. atezolizumab
    US brands: TECENTRIQ
    EU (central) brands: Tecentriq
  34. atibuclimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  35. atidortoxumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  36. atinumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  37. atoltivimab
    US brands, in combination: INMAZEB with maftivimab + odesivimab
    EU (central) brands: none found
  38. atorolimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  39. avdoralimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  40. avelumab
    US brands: BAVENCIO
    EU (central) brands: Bavencio
  41. avizakimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  42. axatilimab
    US brands: NIKTIMVO
    EU (central) brands: none found
  43. azintuxizumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  44. bafisontamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  45. balstilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  46. bamlanivimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  47. bapotulimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  48. barecetamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  49. barzolvolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  50. basiliximab
    US brands: SIMULECT
    EU (central) brands: Simulect
  51. basiliximab sarotalocan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  52. batoclimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  53. bavituximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  54. bavunalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  55. bebtelovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  56. bectumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  57. bedinvetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  58. befovacimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  59. begelomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  60. belantamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  61. belantamab mafodotin
    US brands: BLENREP
    EU (central) brands: Blenrep
  62. belimumab
    US brands: BENLYSTA
    EU (central) brands: Benlysta
  63. beludavimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  64. bemarituzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  65. benralizumab
    US brands: FASENRA
    EU (central) brands: Fasenra
  66. bentracimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  67. benufutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  68. bepranemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  69. berlimatoxumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  70. bermekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  71. bersanlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  72. bertilimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  73. besilesomab
    US brands: none found
    EU (central) brands: Scintimun
  74. betifisolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  75. bevacizumab
    EU (central) brands: Abevmy, Alymsys, Avastin, Avzivi, Aybintio, Lytenava, Mvasi, Oyavas, Vegzelma, Zirabev, Equidacent (withdrawn), Lextemy (withdrawn), Onbevzi (withdrawn)
  76. bevacizumab beta
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  77. bevacizumab gamma
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  78. bexmarilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  79. bezlotoxumab
    US brands: ZINPLAVA
    EU (central) brands: Zinplava
  80. bimekizumab
    US brands: BIMZELX
    EU (central) brands: Bimzelx
  81. birtamimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  82. bivatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  83. bleselumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  84. blinatumomab
    US brands: BLINCYTO
    EU (central) brands: Blincyto
  85. blontuvetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  86. bococizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  87. boserolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  88. botensilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  89. brazikumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  90. brentuximab vedotin
    US brands: ADCETRIS
    EU (central) brands: Adcetris
  91. briakinumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  92. briquilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  93. brodalumab
    US brands: SILIQ
    EU (central) brands: Kyntheum
  94. brolucizumab
    US brands: BEOVU
    EU (central) brands: Beovu
  95. brontictuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  96. budigalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  97. burfiralimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  98. cabiralizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  99. cadonilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  100. camidanlumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  101. camidanlumab tesirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  102. camoteskimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  103. camrelizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  104. canakinumab
    US brands: ILARIS
    EU (central) brands: Ilaris
  105. cantuzumab mertansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  106. cantuzumab ravtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  107. caplacizumab
    US brands: CABLIVI
    EU (central) brands: Cablivi
  108. capromab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  109. carlumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  110. carotuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  111. casirivimab
    US brands: none found
    EU (central) brands, in combination: Ronapreve (withdrawn) with imdevimab
  112. catumaxomab
    US brands: none found
    EU (central) brands: Korjuny, Removab (withdrawn)
  113. cedelizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  114. cemiplimab
    US brands: LIBTAYO
    EU (central) brands: Libtayo
  115. cendakimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  116. cergutuzumab amunaleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  117. certolizumab pegol
    US brands: CIMZIA
    EU (central) brands: Cimzia
  118. cetrelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  119. cetuximab
    US brands: ERBITUX
    EU (central) brands: Erbitux
  120. cetuximab sarotalocan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  121. cevostamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  122. cibisatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  123. cifurtilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  124. cilgavimab
    US brands: none found
    EU (central) brands, in combination: Evusheld (withdrawn) with tixagevimab
  125. cinpanemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  126. cirevetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  127. citatuzumab bogatox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  128. cixutumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  129. clazakizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  130. clenoliximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  131. clesrovimab
    US brands: ENFLONSIA
    EU (central) brands: Enflonsia
  132. clivatuzumab tetraxetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  133. cobolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  134. codrituzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  135. cofetuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  136. cofetuzumab pelidotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  137. coltuximab ravtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  138. conatumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  139. concizumab
    US brands: ALHEMO
    EU (central) brands: Alhemo
  140. coprelotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  141. cosibelimab
    US brands: UNLOXCYT
    EU (central) brands: none found
  142. crefmirlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  143. crefmirlimab berdoxam
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  144. crenezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  145. crizanlizumab
    US brands: ADAKVEO
    EU (central) brands: Adakveo (revoked)
  146. crotedumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  147. crovalimab
    US brands: PIASKY
    EU (central) brands: Piasky
  148. cudarolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  149. cusatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  150. dacetuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  151. daclizumab
    US brands: ZINBRYTA
    EU (central) brands: Zenapax (withdrawn), Zinbryta (withdrawn)
  152. daclizumab beta
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  153. dafsolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  154. dafsolimab setaritox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  155. dalotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  156. dapirolizumab pegol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  157. daratumumab
    US brands: DARZALEX
    EU (central) brands: Darzalex
  158. datopotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  159. datopotamab deruxtecan
    US brands: DATROWAY
    EU (central) brands: Datroway
  160. daxdilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  161. dectrekumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  162. demcizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  163. demupitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  164. denintuzumab mafodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  165. denosumab
  166. depatuxizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  167. depatuxizumab mafodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  168. depemokimab
    US brands: EXDENSUR
    EU (central) brands: Exdensur
  169. derlotuximab biotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  170. detumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  171. dinutuximab
    US brands: UNITUXIN
    EU (central) brands: Unituxin (withdrawn)
  172. dinutuximab beta
    US brands: none found
    EU (central) brands: Qarziba
  173. disitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  174. disitamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  175. divozilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  176. docaravimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  177. domvanalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  178. donanemab
    US brands: KISUNLA
    EU (central) brands: Kisunla
  179. dorlimomab aritox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  180. dostarlimab
    US brands: JEMPERLI
    EU (central) brands: Jemperli
  181. dovanvetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  182. dresbuxelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  183. drozitumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  184. duligotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  185. dupilumab
    US brands: DUPIXENT
    EU (central) brands: Dupixent
  186. durvalumab
    US brands: IMFINZI
    EU (central) brands: Imfinzi
  187. dusigitumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  188. duvortuxizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  189. ebdarokimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  190. eblasakimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  191. ebronucimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  192. ecleralimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  193. ecromeximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  194. eculizumab
    US brands: BKEMV, EPYSQLI, SOLIRIS
    EU (central) brands: Bekemv, Epysqli, Soliris
  195. edrecolomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  196. efalizumab
    US brands: none found
    EU (central) brands: Raptiva (withdrawn)
  197. eldelumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  198. elezanumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  199. elgemtumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  200. elipovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  201. elotuzumab
    US brands: EMPLICITI
    EU (central) brands: Empliciti
  202. elranatamab
    US brands: ELREXFIO
    EU (central) brands: Elrexfio
  203. elsilimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  204. emactuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  205. emapalumab
    US brands: GAMIFANT
    EU (central) brands: none found
  206. emerfetamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  207. emfizatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  208. emibetuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  209. emicizumab
    US brands: HEMLIBRA
    EU (central) brands: Hemlibra
  210. emirodatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  211. enapotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  212. enapotamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  213. enavatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  214. encelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  215. enfortumab vedotin
    US brands: PADCEV
    EU (central) brands: Padcev
  216. enibarcimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  217. enlimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  218. enlimomab pegol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  219. enoblituzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  220. enokizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  221. enoticumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  222. ensituximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  223. enuzovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  224. envafolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  225. epcoritamab
    US brands: EPKINLY
    EU (central) brands: Tepkinly
  226. epitumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  227. epitumomab cituxetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  228. epratuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  229. eptinezumab
    US brands: VYEPTI
    EU (central) brands: Vyepti
  230. erenumab
    US brands: AIMOVIG
    EU (central) brands: Aimovig
  231. erfonrilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  232. erlizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  233. ertumaxomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  234. etaracizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  235. etesevimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  236. etevritamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  237. etigilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  238. etokimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  239. etrolizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  240. evinacumab
    US brands: EVKEEZA
    EU (central) brands: Evkeeza
  241. evolocumab
    US brands: REPATHA
    EU (central) brands: Repatha
  242. exbivirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  243. exidavnemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  244. ezabenlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  245. fanolesomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  246. faralimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  247. faricimab
    US brands: VABYSMO
    EU (central) brands: Vabysmo
  248. farletuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  249. farletuzumab ecteribulin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  250. fasinumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  251. favezelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  252. fazpilodemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  253. felzartamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  254. fezakinumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  255. fianlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  256. ficlatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  257. fidasintamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  258. figitumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  259. finotolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  260. firivumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  261. fiztasovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  262. fladilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  263. flanvotumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  264. fletikumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  265. flotetuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  266. fontolizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  267. foralumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  268. foravirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  269. fremanezumab
    US brands: AJOVY
    EU (central) brands: Ajovy
  270. fresolimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  271. frexalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  272. frovocimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  273. frunevetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  274. fulranumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  275. futuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  276. galcanezumab
    US brands: EMGALITY
    EU (central) brands: Emgality
  277. galegenimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  278. galiximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  279. gancotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  280. ganitumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  281. gantenerumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  282. garadacimab
    US brands: ANDEMBRY
    EU (central) brands: Andembry
  283. garivulimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  284. gatipotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  285. gavilimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  286. gedivumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  287. gefurulimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  288. gemtuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  289. gemtuzumab ozogamicin
    US brands: MYLOTARG
    EU (central) brands: Mylotarg
  290. geptanolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  291. gevokizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  292. gilvetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  293. gimsilumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  294. ginisortamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  295. girentuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  296. girolalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  297. glembatumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  298. glembatumumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  299. glenzocimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  300. glofitamab
    US brands: COLUMVI
    EU (central) brands: Columvi
  301. golimumab
    EU (central) brands: Gobivaz, Gotenfia, Simponi
  302. golocdacimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  303. gontivimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  304. gosuranemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  305. gratalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  306. gremubamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  307. grisnilimab setaritox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  308. gumokimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  309. guselkumab
    US brands: TREMFYA
    EU (central) brands: Tremfya
  310. ianalumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  311. ibalizumab
    US brands: TROGARZO
    EU (central) brands: Trogarzo (withdrawn)
  312. ibritumomab tiuxetan
    US brands: ZEVALIN
    EU (central) brands: Zevalin (lapsed)
  313. icrucumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  314. idactamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  315. idarucizumab
    US brands: PRAXBIND
    EU (central) brands: Praxbind
  316. ieramilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  317. ifabotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  318. ifinatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  319. ifinatamab deruxtecan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  320. igovomab
    US brands: none found
    EU (central) brands: Indimacis 125 (withdrawn)
  321. iladatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  322. iladatuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  323. imalumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  324. imaprelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  325. imciromab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  326. imdevimab
    US brands: none found
    EU (central) brands, in combination: Ronapreve (withdrawn) with casirivimab
  327. imgatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  328. imsidolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  329. imvotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  330. inclacumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  331. indatuximab ravtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  332. indusatumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  333. indusatumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  334. inebilizumab
    US brands: UPLIZNA
    EU (central) brands: Uplizna
  335. inezetamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  336. infliximab
    EU (central) brands: Flixabi, Remicade, Remsima, Zessly, Inflectra (withdrawn)
  337. inolimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  338. inotuzumab ozogamicin
    US brands: BESPONSA
    EU (central) brands: Besponsa
  339. intetumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  340. iparomlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  341. ipilimumab
    US brands: YERVOY
    EU (central) brands: Yervoy
  342. iratumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  343. isatuximab
    EU (central) brands: Sarclisa
  344. iscalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  345. ispectamab debotansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  346. istiratumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  347. itepekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  348. itolizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  349. ivicentamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  350. ivonescimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  351. ivuxolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  352. ixekizumab
    US brands: TALTZ
    EU (central) brands: Taltz
  353. izalontamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  354. izenivetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  355. izuralimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  356. keliximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  357. labetuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  358. labetuzumab govitecan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  359. lacnotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  360. lacutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  361. ladintrevimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  362. ladiratuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  363. ladiratuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  364. lampalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  365. lanadelumab
    US brands: TAKHZYRO
    EU (central) brands: Takhzyro
  366. landogrozumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  367. laprituximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  368. laprituximab emtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  369. larcaviximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  370. latozinemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  371. lebrikizumab
    US brands: EBGLYSS
    EU (central) brands: Ebglyss
  372. lecanemab
    EU (central) brands: Leqembi
  373. lemalesomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  374. lemzoparlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  375. lenvervimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  376. lenzilumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  377. lerdelimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  378. leronlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  379. lesabelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  380. lesofavumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  381. letaplimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  382. letolizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  383. levilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  384. lexatumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  385. libivirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  386. licaminlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  387. lifastuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  388. ligelizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  389. ligufalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  390. lilotomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  391. lilotomab satetraxetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  392. lintuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  393. lintuzumab satetraxetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  394. linvoseltamab
    US brands: LYNOZYFIC
    EU (central) brands: Lynozyfic
  395. lirentelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  396. lirilumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  397. litifilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  398. livmoniplimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  399. lodapolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  400. lodelcizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  401. lokivetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  402. lomtegovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  403. loncastuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  404. loncastuximab tesirine
    US brands: ZYNLONTA
    EU (central) brands: Zynlonta
  405. lonigutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  406. lonigutamab ugodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  407. lorigerlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  408. lorvotuzumab mertansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  409. losatuxizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  410. losatuxizumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  411. lucatumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  412. lulizumab pegol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  413. lumiliximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  414. lumretuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  415. lupartumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  416. lupartumab amadotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  417. lusvertikimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  418. lutikizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  419. luveltamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  420. luveltamab tazevibulin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  421. maftivimab
    US brands, in combination: INMAZEB with atoltivimab + odesivimab
    EU (central) brands: none found
  422. magrolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  423. manelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  424. manfidokimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  425. mapatumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  426. margetuximab
    US brands: MARGENZA
    EU (central) brands: none found
  427. marstacimab
    US brands: HYMPAVZI
    EU (central) brands: Hympavzi
  428. maslimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  429. matuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  430. mavrilimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  431. mazorelvimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  432. mecbotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  433. melrilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  434. mepolizumab
    US brands: NUCALA
    EU (central) brands: Nucala
  435. metelimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  436. mezagitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  437. mibavademab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  438. milatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  439. minretumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  440. mipasetamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  441. mipasetamab uzoptirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  442. miptenalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  443. mirikizumab
    US brands: OMVOH
    EU (central) brands: Omvoh
  444. miromavimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  445. mirvetuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  446. mirvetuximab soravtansine
    US brands: ELAHERE
    EU (central) brands: Elahere
  447. mirzotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  448. mirzotamab clezutoclax
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  449. mitazalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  450. mitumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  451. modotuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  452. mogamulizumab
    US brands: POTELIGEO
    EU (central) brands: Poteligeo
  453. monalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  454. morolimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  455. mosunetuzumab
    EU (central) brands: Lunsumio
  456. motavizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  457. moxetumomab pasudotox
    US brands: LUMOXITI
    EU (central) brands: Lumoxiti (withdrawn)
  458. mupadolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  459. murlentamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  460. nacolomab tafenatox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  461. nadecnemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  462. nadunolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  463. namilumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  464. naptumomab estafenatox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  465. naratuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  466. naratuximab emtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  467. narnatumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  468. narsoplimab
    US brands: YARTEMLEA
    EU (central) brands: none found
  469. natalizumab
    US brands: TYRUKO, TYSABRI
    EU (central) brands: Tyruko, Tysabri
  470. navivumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  471. naxitamab
    US brands: DANYELZA
    EU (central) brands: none found
  472. necitumumab
    US brands: PORTRAZZA
    EU (central) brands: Portrazza (withdrawn)
  473. nemolizumab
    US brands: NEMLUVIO
    EU (central) brands: Nemluvio
  474. nerelimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  475. nesvacumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  476. netakimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  477. nimacimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  478. nimotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  479. nipocalimab
    US brands: IMAAVY
    EU (central) brands: Imaavy
  480. nirsevimab
    US brands: BEYFORTUS
    EU (central) brands: Beyfortus
  481. nivatrotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  482. nivolumab
    US brands: OPDIVO
    in combination: OPDIVO QVANTIG with hyaluronidase-nvhy; OPDUALAG with relatlimab-rmbw
    EU (central) brands: Opdivo, Nivolumab BMS (withdrawn)
    in combination: Opdualag with relatlimab
  483. nofazinlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  484. nofetumomab merpentan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  485. nurulimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  486. obexelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  487. obinutuzumab
    US brands: GAZYVA
    EU (central) brands: Gazyvaro
  488. ocaratuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  489. ociperlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  490. ocrelizumab
    US brands: OCREVUS
    EU (central) brands: Ocrevus
  491. odesivimab
    US brands, in combination: INMAZEB with atoltivimab + maftivimab
    EU (central) brands: none found
  492. odulimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  493. ofatumumab
    US brands: ARZERRA, KESIMPTA
    EU (central) brands: Kesimpta, Arzerra (withdrawn)
  494. olaratumab
    US brands: LARTRUVO (discontinued in FDA listings)
    EU (central) brands: Lartruvo (revoked)
  495. oleclumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  496. olendalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  497. olinvacimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  498. olokizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  499. omalizumab
    US brands: OMLYCLO, XOLAIR
    EU (central) brands: Omlyclo, Xolair
  500. omburtamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  501. omodenbamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  502. onartuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  503. ongericimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  504. ontamalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  505. ontuxizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  506. onvatilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  507. opicinumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  508. oportuzumab monatox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  509. opucolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  510. ordesekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  511. oregovomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  512. orilanolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  513. ormutivimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  514. orticumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  515. osemitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  516. osocimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  517. otilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  518. otlertuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  519. oxelumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  520. ozanezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  521. ozoralizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  522. ozuriftamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  523. ozuriftamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  524. pacanalotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  525. pacmilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  526. palivizumab
    US brands: SYNAGIS
    EU (central) brands: Synagis
  527. pamrevlumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  528. panitumumab
    US brands: VECTIBIX
    EU (central) brands: Vectibix
  529. panobacumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  530. parsatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  531. pascolizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  532. pasotuxizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  533. pateclizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  534. patritumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  535. patritumab deruxtecan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  536. pavurutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  537. pelgifatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  538. pelgifatamab corixetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  539. pembrolizumab
    US brands: KEYTRUDA
    in combination: KEYTRUDA QLEX with berahyaluronidase alfa-pmph
    EU (central) brands: Keytruda
  540. penpulimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  541. pepinemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  542. perakizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  543. peresolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  544. pertuzumab
    US brands: PERJETA, POHERDY
    in combination: PHESGO with and hyaluronidase-zzxf + trastuzumab
    EU (central) brands: Perjeta, Poherdy
    in combination: Phesgo with trastuzumab
  545. pertuzumab zuvotolimod
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  546. pexelizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  547. pidilizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  548. pimivalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  549. pimurutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  550. pinatuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  551. pintumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  552. pivekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  553. pivekimab sunirine
    US brands: DECNUPAZ
    EU (central) brands: none found
  554. placulumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  555. plonmarlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  556. plozalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  557. plutavimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  558. polatuzumab vedotin
    US brands: POLIVY
    EU (central) brands: Polivy
  559. ponezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  560. porgaviximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  561. posdinemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  562. pozelimab
    US brands: VEOPOZ
    EU (central) brands: none found
  563. praluzatamab ravtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  564. prasinezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  565. prezalumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  566. priliximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  567. pritoxaximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  568. pritumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  569. prolgolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  570. pucotenlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  571. pulocimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  572. quavonlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  573. quetmolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  574. quilizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  575. quisovalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  576. racotumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  577. radretumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  578. rafivirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  579. ragifilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  580. ralpancizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  581. ramucirumab
    US brands: CYRAMZA
    EU (central) brands: Cyramza
  582. ranevetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  583. ranibizumab
  584. ravagalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  585. ravulizumab
    US brands: ULTOMIRIS
    EU (central) brands: Ultomiris
  586. raxibacumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  587. recaticimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  588. refanezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  589. regavirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  590. regdanvimab
    US brands: none found
    EU (central) brands: Regkirona (withdrawn)
  591. relatlimab
    US brands, in combination: OPDUALAG with nivolumab
    EU (central) brands, in combination: Opdualag with nivolumab
  592. relfovetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  593. remtolumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  594. reosalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  595. reslizumab
    US brands: CINQAIR
    EU (central) brands: Cinqaero
  596. retifanlimab
    US brands: ZYNYZ
    EU (central) brands: Zynyz
  597. revdofilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  598. rilotumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  599. rimteravimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  600. rinucumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  601. ripertamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  602. risankizumab
    US brands: SKYRIZI
    EU (central) brands: Skyrizi
  603. rituximab
    in combination: RITUXAN HYCELA with hyaluronidase human recombinant
    EU (central) brands: Blitzima, Ituxredi, MabThera, Rixathon, Riximyo, Ruxience, Truxima, Ritemvia (withdrawn), Rituzena (withdrawn)
  604. rivabazumab pegol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  605. robatumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  606. rocatinlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  607. roledumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  608. rolinsatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  609. rolinsatamab talirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  610. romilkimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  611. romlusevimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  612. romosozumab
    US brands: EVENITY
    EU (central) brands: Evenity
  613. rontalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  614. rosmantuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  615. rosnilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  616. rosopatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  617. rosopatamab tetraxetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  618. rovalpituzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  619. rovalpituzumab tesirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  620. rovelizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  621. rozanolixizumab
    US brands: RYSTIGGO
    EU (central) brands: Rystiggo
  622. rulonilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  623. runimotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  624. ruplizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  625. sabatolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  626. sacituzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  627. sacituzumab govitecan
    US brands: TRODELVY
    EU (central) brands: Trodelvy
  628. samalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  629. samrotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  630. samrotamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  631. sarilumab
    US brands: KEVZARA
    EU (central) brands: Kevzara
  632. sasanlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  633. satralizumab
    US brands: ENSPRYNG
    EU (central) brands: Enspryng
  634. satumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  635. secukinumab
    US brands: COSENTYX
    EU (central) brands: Cosentyx
  636. selicrelumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  637. semorinemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  638. semzuvolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  639. serclutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  640. serclutamab salirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  641. seribantumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  642. serplulimab
    US brands: none found
    EU (central) brands: Hetronifly
  643. setoxaximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  644. setrusumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  645. sevirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  646. sibeprenlimab
    US brands: VOYXACT
    EU (central) brands: none found
  647. sibrotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  648. sifalimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  649. siltuximab
    US brands: SYLVANT
    EU (central) brands: Sylvant
  650. simridarlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  651. simtuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  652. sintilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  653. siplizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  654. sirexatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  655. sirtratumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  656. sirtratumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  657. sirukumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  658. socazolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  659. sofituzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  660. solanezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  661. solitomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  662. sonelokimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  663. sontuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  664. sotevtamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  665. sotigalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  666. sotrovimab
    US brands: none found
    EU (central) brands: Xevudy (withdrawn)
  667. spartalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  668. spesolimab
    US brands: SPEVIGO
    EU (central) brands: Spevigo
  669. stamulumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  670. suciraslimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  671. sudubrilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  672. sugemalimab
    US brands: none found
    EU (central) brands: Cejemly
  673. sulesomab
    US brands: none found
    EU (central) brands: LeukoScan (withdrawn)
  674. suptavumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  675. surzebiclimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  676. suvizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  677. suvratoxumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  678. tabalumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  679. tabituximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  680. tabituximab barzuxetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  681. tadocizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  682. tafasitamab
    US brands: MONJUVI
    EU (central) brands: Minjuvi
  683. tafolecimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  684. tagitanlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  685. talacotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  686. talizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  687. talquetamab
    US brands: TALVEY
    EU (central) brands: Talvey
  688. tamgiblimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  689. tamrintamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  690. tamrintamab pamozirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  691. tamtuvetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  692. tanezumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  693. taplitumomab paptox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  694. tarcocimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  695. tarcocimab tedromer
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  696. tarextumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  697. tarlatamab
    US brands: IMDELLTRA
    EU (central) brands: Imdylltra
  698. tavolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  699. tebotelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  700. tecaginlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  701. teclistamab
    US brands: TECVAYLI
    EU (central) brands: Tecvayli
  702. tefibazumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  703. telazorlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  704. telimomab aritox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  705. telisotuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  706. telisotuzumab vedotin
    US brands: EMRELIS
    EU (central) brands: none found
  707. temelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  708. tenatumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  709. teneliximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  710. teplizumab
    US brands: TZIELD
    EU (central) brands: Teizeild
  711. tepoditamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  712. teprotumumab
    US brands: TEPEZZA
    EU (central) brands: Tepezza
  713. teropavimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  714. tesidolumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  715. tesnatilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  716. tezepelumab
    US brands: TEZSPIRE
    EU (central) brands: Tezspire
  717. tibulizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  718. tidutamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  719. tifcemalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  720. tigatuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  721. tilavonemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  722. tildrakizumab
    US brands: ILUMYA
    EU (central) brands: Ilumetri
  723. tilogotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  724. tilvestamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  725. timigutuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  726. timolumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  727. tinurilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  728. tiragolumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  729. tirnovetmab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  730. tislelizumab
    US brands: TEVIMBRA
    EU (central) brands: Tevimbra, Tizveni (withdrawn)
  731. tisotumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  732. tisotumab vedotin
    US brands: TIVDAK
    EU (central) brands: Tivdak
  733. tixagevimab
    US brands: none found
    EU (central) brands, in combination: Evusheld (withdrawn) with cilgavimab
  734. tocilizumab
  735. tomaralimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  736. tomuzotuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  737. toralizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  738. toripalimab
    US brands: LOQTORZI
    EU (central) brands: Loqtorzi
  739. torudokimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  740. tosatoxumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  741. tositumomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  742. tovetumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  743. tozorakimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  744. tralokinumab
    US brands: ADBRY
    EU (central) brands: Adtralza
  745. trastuzumab
    in combination: PHESGO with and hyaluronidase-zzxf + pertuzumab
    in combination: Phesgo with pertuzumab
  746. trastuzumab beta
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  747. trastuzumab botidotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  748. trastuzumab corixetan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  749. trastuzumab deruxtecan
    US brands: ENHERTU
    FDA writes it FAM-TRASTUZUMAB DERUXTECAN
    EU (central) brands: Enhertu
  750. trastuzumab duocarmazine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  751. trastuzumab emtansine
    US brands: KADCYLA
    FDA writes it ADO-TRASTUZUMAB EMTANSINE
    EU (central) brands: Kadcyla
  752. trastuzumab imbotolimod
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  753. trastuzumab rezetecan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  754. trastuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  755. tregalizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  756. tremelimumab
    US brands: IMJUDO
    EU (central) brands: Imjudo, Tremelimumab AstraZeneca (withdrawn)
  757. trevogrumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  758. trinbelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  759. trontinemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  760. tucotuzumab celmoleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  761. tusamitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  762. tusamitamab ravtansine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  763. tuvirumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  764. tuvonralimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  765. ubamatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  766. ublituximab
    US brands: BRIUMVI
    EU (central) brands: Briumvi
  767. ulenistamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  768. uliledlimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  769. ulocuplumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  770. unasnemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  771. upanovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  772. urabrelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  773. urelumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  774. ustekinumab
    EU (central) brands: Fymskina, Imuldosa, Otulfi, Pyzchiva, Stelara, Steqeyma, Usgena, Usrenty, Usymro, Uzpruvo, Wezenla, Yesintek
    3 moreAbsimky (withdrawn), Eksunbi (withdrawn), Qoyvolma (withdrawn)
  775. utomilumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  776. vadastuximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  777. vadastuximab talirine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  778. vandortuzumab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  779. vantictumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  780. vanucizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  781. vapaliximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  782. varisacumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  783. varlilumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  784. vatelizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  785. vedolizumab
    US brands: ENTYVIO
    EU (central) brands: Entyvio
  786. veltuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  787. vepalimomab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  788. vepsitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  789. vesencumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  790. vibecotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  791. vibostolimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  792. vilobelimab
    US brands: none found
    EU (central) brands: Gohibic
  793. visilizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  794. vixarelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  795. vixtimotamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  796. vobarilizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  797. vobramitamab duocarmazine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  798. vofatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  799. volagidemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  800. volociximab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  801. vonlerolizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  802. vopratelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  803. vorsetuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  804. vorsetuzumab mafodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  805. votumumab
    US brands: none found
    EU (central) brands: HumaSPECT (withdrawn)
  806. voxalatamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  807. vudalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  808. vulinacimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  809. vunakizumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  810. xeligekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  811. xentuzumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  812. zagotenemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  813. zalifrelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  814. zalutumumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  815. zamerovimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  816. zampilimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  817. zanidatamab zovodotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  818. zanolimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  819. zansecimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  820. zelminemab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  821. zeluvalimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  822. zenocutuzumab
    US brands: BIZENGRI
    EU (central) brands: none found
  823. zilovertamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  824. zilovertamab vedotin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  825. ziltivekimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  826. zimberelimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  827. zinlirvimab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  828. ziralimumab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  829. zolbetuximab
    US brands: VYLOY
    EU (central) brands: Vyloy
  830. zolimomab aritox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  831. zuberitamab
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Decode another name

Decoded

atinumab

Listed INNCarries the WHO stem -mab

  • -mabend of the nameWHO lists it hereWHO definition: monoclonal antibodies (previous naming scheme)

“atinumab” is an INN that WHO lists under -mab in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -mab (Part II B) and the 831 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy